Alyeska Investment Group L.P. Purchases Shares of 224,607 UnitedHealth Group Inc (UNH)

Alyeska Investment Group L.P. purchased a new position in UnitedHealth Group Inc (NYSE:UNH) during the fourth quarter, Holdings Channel reports. The firm purchased 224,607 shares of the healthcare conglomerate’s stock, valued at approximately $35,946,000.

Several other institutional investors also recently bought and sold shares of UNH. Independent Portfolio Consultants Inc. raised its position in UnitedHealth Group by 531.3% in the third quarter. Independent Portfolio Consultants Inc. now owns 1,010 shares of the healthcare conglomerate’s stock worth $141,000 after buying an additional 850 shares during the last quarter. Fisher Asset Management LLC raised its position in UnitedHealth Group by 26.7% in the third quarter. Fisher Asset Management LLC now owns 3,782 shares of the healthcare conglomerate’s stock worth $529,000 after buying an additional 796 shares during the last quarter. Carroll Financial Associates Inc. raised its position in UnitedHealth Group by 6.2% in the third quarter. Carroll Financial Associates Inc. now owns 1,858 shares of the healthcare conglomerate’s stock worth $260,000 after buying an additional 108 shares during the last quarter. Perkins Coie Trust Co raised its position in UnitedHealth Group by 1.3% in the third quarter. Perkins Coie Trust Co now owns 18,751 shares of the healthcare conglomerate’s stock worth $2,625,000 after buying an additional 235 shares during the last quarter. Finally, Creative Planning raised its position in UnitedHealth Group by 19.3% in the third quarter. Creative Planning now owns 39,862 shares of the healthcare conglomerate’s stock worth $5,581,000 after buying an additional 6,447 shares during the last quarter. 86.67% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Inc (NYSE:UNH) opened at 165.00 on Monday. UnitedHealth Group Inc has a 52-week low of $125.26 and a 52-week high of $172.14. The firm’s 50-day moving average price is $165.26 and its 200-day moving average price is $153.64. The stock has a market cap of $156.94 billion, a P/E ratio of 22.76 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 17th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.07 by $0.04. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The firm earned $47.50 billion during the quarter, compared to the consensus estimate of $47.12 billion. During the same quarter in the previous year, the firm posted $1.40 EPS. The company’s revenue for the quarter was up 9.0% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Inc will post $9.51 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 21st. Stockholders of record on Friday, March 10th were given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date was Wednesday, March 8th. UnitedHealth Group’s payout ratio is 33.47%.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Mideast Time and is the property of of Mideast Time. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.mideasttime.com/alyeska-investment-group-l-p-purchases-shares-of-224607-unitedhealth-group-inc-unh/1588958.html.

UNH has been the subject of a number of analyst reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, November 29th. Mizuho raised UnitedHealth Group from a “neutral” rating to a “buy” rating and set a $178.00 price target for the company in a report on Wednesday, November 30th. Leerink Swann raised their price target on UnitedHealth Group from $185.00 to $195.00 and gave the stock an “outperform” rating in a report on Wednesday, November 30th. Jefferies Group LLC increased their price objective on UnitedHealth Group from $168.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, November 30th. Finally, Royal Bank of Canada increased their price objective on UnitedHealth Group from $168.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. One equities research analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $177.10.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Tuesday, February 14th. The shares were sold at an average price of $162.68, for a total transaction of $813,400.00. Following the completion of the sale, the director now owns 75,391 shares of the company’s stock, valued at approximately $12,264,607.88. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Tuesday, January 31st. The shares were sold at an average price of $161.68, for a total transaction of $1,616,800.00. Following the sale, the director now directly owns 1,921,191 shares of the company’s stock, valued at approximately $310,618,160.88. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,310 shares of company stock valued at $5,855,416. Insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.